- £226.61m
- £770.91m
- £2.81bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,679 | 3,325 | 3,183 | 3,015 | 2,815 |
Cost of Revenue | |||||
Gross Profit | 996 | 684 | 676 | 716 | 592 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,678 | 3,325 | 2,849 | 2,927 | 2,869 |
Operating Profit | 0.4 | -0.6 | 333 | 87.3 | -54.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -62.6 | -49.4 | 286 | 61.4 | -107 |
Provision for Income Taxes | |||||
Net Income After Taxes | -59.1 | -1.8 | 224 | 76 | -181 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -64.2 | 14 | 225 | 74.8 | -178 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -64.2 | 14 | 225 | 74.8 | -178 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.186 | 0.133 | 0.133 | 0.086 | 0.001 |